COX-2 expression in gastric cancer and its relationship with lymphangiogenesis and lymph node metastasis
Yu Ying
Abstract
Yu Ying
Abstract
Objective To investigate the expression of cyclooxygenase- 2 (COX- 2) and vascular endothelial growth factor- C (VEGF- C) in human gastric cancer,the relationship between their expression and the clinicopathological features, as well as the relationship between these two parameter expression and lymphangiogenesis and lymph node metastasis. Methods COX- 2 and VEGF- C expressions were detected in 63 gastric cancer samples by immunostaining. Lymphanigogenesis was evaluated by immunostaining with the specific antibody LYVE- 1. Results The expression rates of COX- 2 and VEGF- C were 66.7% (42/63),52.4% (33/63),respectively in 63 gastric cancer specimens. LYVE- 1 was positive in 35 cases (35/63),which indicated lymphangiogenesis in the tumors. The expression of COX- 2 was significantly correlated with the expression of VEGF- C,tumor lymphangiogenesis and lymphatic metastasis (P 0.05),however not gender,tumor size,tumor location,Lauren classification and serosa invasion (P 0.05). Conclusions In gastric cancer,the expression of COX- 2 is significantly associated with VEGF- C expression,lymphangiogenesis and lymphatic metastasis. COX- 2 may up- regulate the expression of VEGF- C,which induces lymphangiogenesis and accordingly contributes to lymphatic metastasis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression of cyclooxygenase- 2 (COX- 2) and vascular endothelial growth factor- C (VEGF- C) in human gastric cancer,the relationship between their expression and the clinicopathological features, as well as the relationship between these two parameter expression and lymphangiogenesis and lymph node metastasis. Methods COX- 2 and VEGF- C expressions were detected in 63 gastric cancer samples by immunostaining. Lymphanigogenesis was evaluated by immunostaining with the specific antibody LYVE- 1. Results The expression rates of COX- 2 and VEGF- C were 66.7% (42/63),52.4% (33/63),respectively in 63 gastric cancer specimens. LYVE- 1 was positive in 35 cases (35/63),which indicated lymphangiogenesis in the tumors. The expression of COX- 2 was significantly correlated with the expression of VEGF- C,tumor lymphangiogenesis and lymphatic metastasis (P 0.05),however not gender,tumor size,tumor location,Lauren classification and serosa invasion (P 0.05). Conclusions In gastric cancer,the expression of COX- 2 is significantly associated with VEGF- C expression,lymphangiogenesis and lymphatic metastasis. COX- 2 may up- regulate the expression of VEGF- C,which induces lymphangiogenesis and accordingly contributes to lymphatic metastasis.
Key concepts: Lymphangiogenesis, Medicine, Immunostaining, Lymphatic vessel, Lymphatic system, Pathology, Metastasis, Cancer